PFI-RP: Organic Photoredox Catalysts for Improving Commercial Pharmaceutical Production

PFI-RP：用于改善商业药品生产的有机光氧化还原催化剂

• 批准号: 2016557
• 负责人: Garret Miyake
• 金额: $ 55万
• 依托单位: Colorado State University
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-15 至 2024-01-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2016557&HistoricalAwards=false
• 关键词: PFI; RP; Organic; Photoredox; Catalysts

The broader impact/commercial potential of this Partnerships for Innovation – Research Partnerships (PFI-RP) project is the establishment of a new technology enabling the pharmaceutical industry to expedite drug discovery and improve manufacturing capabilities. This technology facilitates access to new chemical reactivity that will provide enhanced abilities to synthesize pharmaceutical products while also allowing milder and safer reaction conditions. The capabilities of this technology to beneficially impact pharmaceutical syntheses will be identified and developed, ultimately providing a needed methodology for rapid and economical drug discovery and pharmaceutical manufacturing. This work will enhance the scientific understanding of using energy from light to drive chemical transformations. Through this work, the societal need for new and affordable medicines will be addressed through commercialization of this breakthrough chemical technology. A catalyst technology implemented across the patent life of a single drug has a commercial potential exceeding $100M. This collaborative effort also supports the training and education of student researchers through a multidisciplinary effort. Student researchers will be exposed to industrial research environments and processes and commercialization concepts that will help build a stronger foundation for becoming future leaders in innovation and entrepreneurship. The proposed project will establish a new catalyst technology for the reduction of arenes in medicinally important, chemical transformations. Catalysis reactions often require harsh reaction conditions or unsustainable, expensive, and toxic precious metal complexes. This project will develop a new class of organic molecules as catalysts that use light energy to perform reactions under mild reaction conditions. This team will use a combination of computational chemistry, machine learning, and artificial intelligence to identify improved catalyst designs and discovery of new chemical reactions. Specifically, the team will establish new capabilities for chemical synthesis that have been largely underdeveloped by the pharmaceutical industry. Success in achieving the goals of this work will result in new photoredox catalysts and the discovery of new chemical reactivities. Overcoming the technical challenges of this work will accelerate the adoption of photoredox catalysis in the pharma and chemical industries and academia. Furthermore, this project will extend artificial intelligence and machine learning to develop predictive models for accelerated catalyst and reaction discovery. Lastly, capabilities to scale photoredox catalyzed reactions will be developed to promote reaction efficiency throughout the broader chemical community.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

该创新-研究伙伴关系（PFI-RP）项目的更广泛影响/商业潜力是建立一种新技术，使制药行业能够加快药物发现并提高制造能力。该技术有助于获得新的化学反应性，这将提供增强的合成药物产品的能力，同时还允许更温和和更安全的反应条件。这项技术的能力，以有利的影响药物合成将被确定和发展，最终提供了一个快速和经济的药物发现和制药所需的方法。这项工作将增强对利用光能驱动化学转化的科学理解。通过这项工作，社会对新的和负担得起的药物的需求将通过这一突破性化学技术的商业化得到解决。在单一药物的专利期限内实施的催化剂技术具有超过1亿美元的商业潜力。这种合作努力还通过多学科的努力支持学生研究人员的培训和教育。学生研究人员将接触到工业研究环境和流程以及商业化概念，这将有助于为成为未来创新和创业的领导者奠定更坚实的基础。 拟议的项目将建立一种新的催化剂技术，用于减少具有医学重要性的化学转化中的芳烃。催化反应通常需要苛刻的反应条件或不可持续的、昂贵的和有毒的贵金属络合物。该项目将开发一类新的有机分子作为催化剂，利用光能在温和的反应条件下进行反应。该团队将使用计算化学，机器学习和人工智能的组合来识别改进的催化剂设计和发现新的化学反应。具体而言，该团队将建立制药行业基本上不发达的化学合成新能力。成功实现这项工作的目标将导致新的光氧化还原催化剂和新的化学反应性的发现。克服这项工作的技术挑战将加速在制药和化学工业以及学术界采用光氧化还原催化。此外，该项目将扩展人工智能和机器学习，以开发加速催化剂和反应发现的预测模型。最后，将开发规模化光氧化还原催化反应的能力，以提高整个更广泛的化学界的反应效率。该奖项反映了NSF的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。